ERYTECH provides financial update for Q1 2013 Post author:admERY Post published:June 3, 2013 Post category:Newsroom ERYTECH announced today its cash position and its revenues for first quarter 2013. You Might Also Like ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019 ERYTECH to Participate in the Upcoming April Investor Conferences March 28, 2022 ERYTECH Announces $7.85 Million Registered Direct Offering December 14, 2021
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer November 25, 2019
